  Neuroimaging biomarkers that distinguish between typical brain aging and
Alzheimer's disease (AD) are valuable for determining how much each contributes
to cognitive decline. Machine learning models can derive multi-variate brain
change patterns related to the two processes, including the SPARE-AD (Spatial
Patterns of Atrophy for Recognition of Alzheimer's Disease) and SPARE-BA (of
Brain Aging) investigated herein. However, substantial overlap between brain
regions affected in the two processes confounds measuring them independently.
We present a methodology toward disentangling the two. T1-weighted MRI images
of 4,054 participants (48-95 years) with AD, mild cognitive impairment (MCI),
or cognitively normal (CN) diagnoses from the iSTAGING (Imaging-based
coordinate SysTem for AGIng and NeurodeGenerative diseases) consortium were
analyzed. First, a subset of AD patients and CN adults were selected based
purely on clinical diagnoses to train SPARE-BA1 (regression of age using CN
individuals) and SPARE-AD1 (classification of CN versus AD). Second, analogous
groups were selected based on clinical and molecular markers to train SPARE-BA2
and SPARE-AD2: amyloid-positive (A+) AD continuum group (consisting of A+AD,
A+MCI, and A+ and tau-positive CN individuals) and amyloid-negative (A-) CN
group. Finally, the combined group of the AD continuum and A-/CN individuals
was used to train SPARE-BA3, with the intention to estimate brain age
regardless of AD-related brain changes. Disentangled SPARE models derived brain
patterns that were more specific to the two types of the brain changes.
Correlation between the SPARE-BA and SPARE-AD was significantly reduced.
Correlation of disentangled SPARE-AD was non-inferior to the molecular
measurements and to the number of APOE4 alleles, but was less to AD-related
psychometric test scores, suggesting contribution of advanced brain aging to
these scores.
